Telemedicine in rheumatology: COVID-19 and beyond

Doctor on computer consulting with patient

During the COVID-19 pandemic, the use of telehealth has increased in rheumatology practice, in line with many other areas of medicine, to enable healthcare delivery while reducing patients’ and providers’ risk for SARS-CoV-2 infection. Here we take a look at how telemedicine is used in rheumatology, explore the advantages and disadvantages, and outline what the […]

Rituximab use in the COVID-19 era: Striking the right balance

Doctor holding Cloud of justice and law- icon bubble with data 3d rendering

With rituximab-treated patients having an elevated risk for severe COVID-19 and a reduced likelihood of responding to vaccines, Sebastian Sattui and David Jayne discuss how these challenges can be addressed and explore the future role of the drug for the treatment of rheumatic diseases (13:17) 00:00 Introduction to the speakers00:26 The current situation with rituximab and […]

Time to reconsider the person with shortness of breath: EMPEROR-Preserved Recorded: Monday, October 11, 2021Broadcast: Thursday, October 21, 2021 Meet the faculty Alice Cheng Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto. Lars Rydén (Chair) Lars Rydén is Senior Professor of Cardiology at the Karolinska Institute, Stockholm, Sweden. He is […]

DKD treatment update: SGLT2 inhibitors and finerenone

Nephrologist Ian de Boer joins primary care physician Amrit Lamba to discuss how the recent approval of finerenone and extension of the dapagliflozin label is likely to influence the treatment of kidney disease in people with type 2 diabetes. 0:00 Introduction 1:40 The DAPA-CKD trial: Building on CREDENCE 5:01 How the trial findings will influence primary care 7:10 Safety […]

COVID-19 Global Rheumatology Alliance study finds link between RA treatment and COVID-19 severity

Jeffrey Sparks and Zachary Wallace talk about the potential for COVID-19 being more severe in rheumatoid arthritis patients treated with rituximab or JAK inhibitors rather than TNF inhibitors (8:06). Transcript We performed our study among rheumatoid arthritis patients, all of whom had COVID-19 and all of which were being treated with either biologic or […]

COVID-19 vaccination in patients with cancer

Covid-19 vaccine

We speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as the timing of vaccine administration, the importance of monitoring side effects, and the key unanswered research questions. Listen below or subscribe to this podcast on: Apple Podcasts | Spotify | Google Podcasts | Stitcher | TuneIn About […]

Metastatic urothelial cancer: clinical insights into trial data

human urinary system kidneys with bladder

Shilpa Gupta and Petros Grivas share their thoughts on the key practicing-changing trials in metastatic urothelial cancer, including EV-301, EV-201, TITAN-TCC, and TROPiCS-04, and discuss the emerging role of antibody–drug conjugates in the evolving treatment landscape (16:47).